Monday, December 3, 2018

Ready to evaluate structures and transactions to assuage investor concerns: Sun Pharma

Ready to evaluate structures and transactions to assuage investor concerns: Sun Pharma "As of now, the company has not received any query from SEBI with regards to whistleblower complaint, Sun Pharma founder and MD Dilip Shanghvi said.

from Moneycontrol Business News https://ift.tt/2DVsfeK

No comments:

Post a Comment

Bajaj Auto shares fall 2% as firm, subsidiary fall prey to ransomware attack

Bajaj Auto shares dipped 2% following a ransomware attack on its systems and subsidiary, Bajaj Auto Technology Ltd, on June 23, 2026. The co...